MIR22HG suppressed gastric cancer progression through attenuating NOTCH2 signaling [20] MIR22HG repressed cell proliferation, migration and invasion in CCA by negatively regulating the Wnt/β-catenin signaling pathway [18]. The gene discussed is MIR22HG; the disease is gastric cancer.